Background Misconceptions about ADHD stigmatize affected people, reduce credibility of
providers, and prevent/delay treatment. To challenge misconceptions, we curated findings …

Background The benefits and safety of medications for attention-deficit hyperactivity disorder
(ADHD) remain controversial, and guidelines are inconsistent on which medications are …

OBJECTIVES: To study the national prevalence of 10 developmental disabilities in US
children aged 3 to 17 years and explore changes over time by associated demographic and …

2. Method A total of 241 parents of school aged children with ADHD diagnosis were invited
to participate in this survey. The school aged children described in the study were 6–15 …

Mental health symptoms and disorders are common among elite athletes, may have sport
related manifestations within this population and impair performance. Mental health cannot …

The purpose of this study is to estimate the national prevalence of parent-reported attention
deficit/hyperactivity disorder (ADHD) diagnosis and treatment among US children 2–17 …

As early as the 1920s, and subsequently in the 1959 Build and Blood Pressure Study (S1. 5-
1) of almost 5 million adults insured between 1934 and 1954, a strong direct relationship …

Attention-deficit hyperactivity disorder (ADHD) is a common childhood behavioural disorder.
Systematic reviews indicate that the community prevalence globally is between 2% and 7 …

Importance Attention-deficit/hyperactivity disorder (ADHD) is common in US children and
adolescents. It is important to understand the most recent prevalence of ADHD and its long …

Psychostimulants, including amphetamines and methylphenidate, are first-line
pharmacotherapies for individuals with attention-deficit/hyperactivity disorder (ADHD). This …